Amy Perrin Ross, APN, MSN, CNRN, MSCN
Reports from the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), which took place October 13−16, 2010, in Gothenburg, Sweden, suggest that now is certainly an exciting time, with the promise of improved treatment outcomes and expanded therapeutic options for people with MS.
O'Connor KC, Lopez-Amaya C, Gagne D, et al. J Neuroimmunol. 2010;223:92-99.
This educational activity offers clinicians the latest techniques for communicating information about pregnancy to patients with MS. Additional patient education materials about MS drugs and cognitive dysfunction are also provided after successful completion of the activity.
We encourage you to submit your questions on multiple sclerosis treatment and care to our Steering Committee. We post selected questions and corresponding answers.
Dawn Langdon, PhD
Reader in Neuropsychology
Royal Holloway
University of London
Egham, Surrey, United Kingdom
| Noteworthy in MS News |
|
This website is funded through an educational grant from Bayer HealthCare Pharmaceuticals
